Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study
Sign Up to like & getrecommendations! Published in 2019 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-019-04404-0
Abstract: To compare treatment efficacy of anti-VEGF medications following pro re nata (PRN, “as needed”, monthly injections only in case of active disease) or treat and extend (T&E, progressive extension of treatment intervals up to 12… read more here.
Keywords: treatment; group; ranibizumab aflibercept; prn ... See more keywords
Frequency of and factors related to pro re nata (PRN) medication use in aged care services
Sign Up to like & getrecommendations! Published in 2018 at "Research in Social and Administrative Pharmacy"
DOI: 10.1016/j.sapharm.2017.11.004
Abstract: Background: Little is known about the contribution of ‘pro re nata’ (PRN) medications to overall medication burden in residential aged care services (RACS). Objectives: To determine the frequency of, and factors associated with PRN medication… read more here.
Keywords: nata prn; aged care; medication; prn medication ... See more keywords
Five‐year outcomes of a personalized pro re nata treatment regimen with anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
Sign Up to like & getrecommendations! Published in 2019 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13840
Abstract: draping. Standard peritomy and rectus muscle slinging followed. A 25G endoilluminationchandelier light source (Synergetics, O’Fallon, MO, USA) was placed superonasally, 4 mm posterior to the limbustoallowvisualizationoftheretinausing a BIOM wide-angle noncontact microscope-mounted viewing system (Oculus Surgical,… read more here.
Keywords: personalized pro; five year; outcomes personalized; year outcomes ... See more keywords
One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Ophthalmology"
DOI: 10.1155/2019/7530458
Abstract: Purpose. To compare the functional and anatomical outcomes of one dose and three loading doses followed by the pro re nata (PRN) regimen in Chinese neovascular age-related macular degeneration (nvAMD) (including polypoidal choroidal vasculopathy (PCV))… read more here.
Keywords: prn group; loading doses; followed pro; group ... See more keywords
One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000461785
Abstract: Purpose: We compared 1-year outcomes of 1 + pro re nata (PRN) versus 3 + PRN of intravitreal aflibercept injection (IAI) for age-related macular degeneration (AMD). Methods: Forty-two eyes with naïve AMD received 3 +… read more here.
Keywords: age related; intravitreal aflibercept; aflibercept injection; year outcomes ... See more keywords
Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000477498
Abstract: Purpose: To evaluate the long-term outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) drugs with a pro re nata (PRN) regimen for the treatment of choroidal neovascularization (CNV) secondary to angioid streaks (AS). Methods: This… read more here.
Keywords: choroidal neovascularization; intravitreal anti; long term; treatment ... See more keywords